Now Congressional Democrats, while only having a razor-thin majority in the Senate, are planning a major push to include in measures to lower drug prices in upcoming legislation meant to rebuild the U.S. infrastructure. .TSCL's Board of Trustees Meets with Members of Congress .Deductible: During the initial deductible, the beneficiary pays 100% of the cost of the drug—up to 5 depending on the plan. Many plans provide immediate coverage on generics, and even preferred brand drugs "before the deductible." In this type of plan, you only pay the full price up to the deductible on higher tier drugs, and some plans don't charge a deductible at all. .Specialty-tier drugs are defined by Medicare, as those that cost more than 0 per month in 2019, and include drugs used to treat cancer, hepatitis C, multiple sclerosis (MS), and rheumatoid arthritis. Even when Part D enrollees reach the Medicare Part D catastrophic coverage phase, when co-insurance drops to 5%, beneficiaries who take these drugs can continue to face thousands of dollars in annual out-of-pocket costs, according to the Kaiser study. The study found that annual out-of-pocket costs for specialty drugs in 2019 are expected to average ,994 across the 28 specialty-tier drugs that are covered by drug plans. .If Congress considers cuts to the COLA, changes in the benefit formula and increases in the retirement age, special attention will be needed regarding when changes would become effective and how they would be phased-in. The recession is already having a significant impact on the growth of Social Security benefits. If Congress cuts benefits, or reduces the growth in benefits during this slow recovery, it will likely produce a long lasting double-whammy effect for retirees. .Lower prescription drug prices is one of our top priorities and we will continue to fight for them as long as it takes, and for whatever actions it takes to reduce them. .House Adjourns for Five-Week Summer Recess .TSCL is hopeful that lawmakers will pass a stopgap measure before the October deadline, since a government shutdown could negatively impact Social Security and Medicare beneficiaries. We will keep a close eye on the evolving negotiations over the next two weeks, and we will post updates here in the Legislative News section of our website. .As TSCL supporters well know, Congress has not been able to accomplish significant legislative reform to the convoluted drug pricing system even though anger about high drug prices has been rising for a long time.